Dataset Information


NFAT-Specific Inhibition by dNP2-VIVITAmeliorates Autoimmune Encephalomyelitisby Regulation of Th1 and Th17.

ABSTRACT: Nuclear factor of activated T cells (NFATs) is an important transcription factor for T cell activation and proliferation. Recent studies have highlighted the role of NFATs in regulating the differentiation of effector CD4 T helper (Th) subsets including Th1 and Th17 cells. Because controlling the effector T cell function is important for the treatment of autoimmune diseases, regulation of NFAT functions in T cells would be an important strategy to control the pathogenesis of autoimmune diseases. Here, we demonstrated that an NFAT inhibitory peptide, VIVIT conjugated to dNP2 (dNP2-VIVIT), a blood-brain barrier-permeable peptide, ameliorated experimental autoimmune encephalomyelitis (EAE) by inhibiting Th1 and Th17 cells, but not regulatory T (Treg) cells. dNP2-VIVIT negatively regulated spinal cord-infiltrating interleukin-17A (IL-17A) and interferon (IFN)-?-producing CD4+ T cells without affecting the number of Foxp3+ CD4+ Treg cells, whereas dNP2-VEET or 11R-VIVIT could not significantly inhibit EAE. In comparison with cyclosporin A (CsA), dNP2-VIVIT selectively inhibited Th1 and Th17 differentiation, whereas CsA inhibited the differentiation of all T cell subsets including that of Th2 and Treg cells. Collectively, this study demonstrated the role of dNP2-VIVIT as a novel agent for the treatment of autoimmune diseases such as multiple sclerosis by regulating the functions of Th1 and Th17 cells.


PROVIDER: S-EPMC6849366 | BioStudies | 2020-01-01

REPOSITORIES: biostudies

Similar Datasets

2008-01-01 | S-EPMC2546564 | BioStudies
2002-01-01 | S-EPMC1222985 | BioStudies
2020-01-01 | S-EPMC7053182 | BioStudies
2011-01-01 | S-EPMC3169434 | BioStudies
1000-01-01 | S-EPMC428456 | BioStudies
2014-01-01 | S-EPMC4255985 | BioStudies
1000-01-01 | S-EPMC2823422 | BioStudies
2010-11-08 | GSE25175 | GEO
2008-01-01 | S-EPMC2174201 | BioStudies
2010-11-08 | E-GEOD-25175 | ArrayExpress